Ameliorative role of SIRT1 in peritoneal fibrosis: an in vivo and in vitro study

Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition

(2020) Weibin Qian et al.   Aging-US

SIRT1-modified human umbilical cord mesenchymal stem cells ameliorate experimental peritoneal fibrosis by inhibiting the TGF-β/Smad3 pathway

(2020) Yanhong Guo et al.   Stem Cell Research & Therapy

CX3CL1–CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis

(2019) Alexandra Helmke et al.   KIDNEY INTERNATIONAL

Effect of Peritoneal Dialysis on Serum Fibrosis Biomarkers in Patients with Refractory Congestive Heart Failure

(2019) Margarita Kunin et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CXCR4-Receptor-Targeted Liposomes for the Treatment of Peritoneal Fibrosis

(2019) Khan Asifullah et al.   MOLECULAR PHARMACEUTICS

Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway

(2019) Na Jiang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis

(2019) Nobuyuki Ashizawa et al.   Scientific Reports

PKCδ Mediates NF-κB Inflammatory Response and Downregulates SIRT1 Expression in Liver Fibrosis

(2019) Lee et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Protective mechanism of SIRT1 on Hcy‐induced atrial fibrosis mediated by TRPC3

(2019) Lu Han et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Inflammatory macrophages switch to CCL17‐expressing phenotype and promote peritoneal fibrosis

(2019) Yi‐Ting Chen et al.   JOURNAL OF PATHOLOGY

Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway

(2019) Ying Zhang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice

(2018) Min Li et al.   FASEB JOURNAL

Protein kinase C beta deficiency increases glucose-mediated peritoneal damage via M1 macrophage polarization and up-regulation of mesothelial protein kinase C alpha

(2018) Michael S Balzer et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

HIF1A and VEGF regulate each other by competing endogenous RNA mechanism and involve in the pathogenesis of peritoneal fibrosis

(2018) Juan Li et al.   PATHOLOGY RESEARCH AND PRACTICE

Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis

(2017) Bo Young Nam et al.   Molecular Therapy-Nucleic Acids

Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis

(2016) Raffaele Strippoli et al.   Stem Cells International

Erratum: Corrigendum: Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis

(2016) Lina Sun et al.   Scientific Reports

TGF-β1-siRNA delivery with nanoparticles inhibits peritoneal fibrosis

(2015) H Yoshizawa et al.   GENE THERAPY

Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis

(2014) Pawel Zerr et al.   ANNALS OF THE RHEUMATIC DISEASES

miR-30a Negatively Regulates TGF-β1–Induced Epithelial-Mesenchymal Transition and Peritoneal Fibrosis by Targeting Snai1

(2013) Qin Zhou et al.   AMERICAN JOURNAL OF PATHOLOGY

Sirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF-β/Smad3 Pathway

(2013) Xin-Zhong Huang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling

(2013) Toshinori Ueno et al.   KIDNEY INTERNATIONAL

New insights into the pathogenesis and treatment of peritoneal fibrosis: A potential role of Wnt/β-catenin induced epithelial to mesenchymal transition and stem cells for therapy

(2013) Fan Zhang et al.   MEDICAL HYPOTHESES

Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro

(2011) Xiao-Ming Meng et al.   KIDNEY INTERNATIONAL

Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats

(2010) Yi-Maun Subeq et al.   CYTOKINE

The Pathophysiology of the Peritoneal Membrane

(2010) O. Devuyst et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

BMP-7 stops TGF-  in peritoneal fibrosis

(2010) A. O. Phillips et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The Role of the TGF/Smad Signaling Pathway in Peritoneal Fibrosis Induced by Peritoneal Dialysis Solutions

(2008) Qiang Yao et al.   NEPHRON EXPERIMENTAL NEPHROLOGY